|

ZN-c3 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Azenosertib, KP-2638, Study drug, azenosertib

Anchorage, Alaska1 trial

A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

Alaska Women's Cancer Care

Phase 2

Aurora, Colorado1 trial

A Study of ZN-c3 in Patients With Ovarian Cancer

Site 0264

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.